English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 09, 2025 21:58 HKT
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
Jun 09, 2025 20:30 HKT
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
Jun 09, 2025 19:30 HKT
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
Jun 09, 2025 17:00 HKT
雲頂新耀EVER001亮相ERA 2025 探索原發性膜性腎病治療新路徑
Jun 09, 2025 12:47 HKT
云顶新耀EVER001亮相ERA 2025 探索原发性膜性肾病治疗新路径
Jun 09, 2025 12:35 HKT
光大控股成功發行30億元人民幣熊貓中期票據
Jun 09, 2025 10:07 HKT
光大控股成功发行30亿元人民币熊猫中期票据
Jun 09, 2025 10:00 HKT
冠君产业信托呈献“Lupus Reimagined”艺术展 以艺术连结社区 共创多元共融未来
Jun 06, 2025 19:22 HKT
Champion REIT Presents 'Lupus Reimagined' Art Exhibition, Connecting Community Through Art
Jun 06, 2025 18:55 HKT
冠君產業信託呈獻「Lupus Reimagined」藝術展 以藝術連結社區 共創多元共融未來
Jun 06, 2025 18:23 HKT
稀有中高端冷冻海产上市公司大洋环球上月跑赢大市 最新财报有启示?
Jun 06, 2025 16:16 HKT
Tredu.com Launches Global Platform to Revolutionize Trading Education
Jun 06, 2025 16:00 HKT
International Consortium Rolls Out Major EV Battery Swapping Initiative in Tokyo
Jun 06, 2025 15:42 HKT
Tredu.com Launches Global Platform to Revolutionize Trading Education
Jun 06, 2025 15:40 HKT
稀有中高端冷凍海產上市公司大洋環球上月跑贏大市 最新財報有啟示?
Jun 06, 2025 15:02 HKT
政社企聯手送暖 深水埗白田邨1500居民喜獲端午福袋
Jun 06, 2025 13:44 HKT
富士通、人とAIの協働により、ネットポジティブな未来につなげるアクションを示す「Fujitsu Technology and Service Vision 2025」を策定
Jun 06, 2025 10:15 HKT
TANAKA PRECIOUS METAL TECHNOLOGIES, ‘PEM형 수전해용 전극촉매 개발 및 실용화’가 ‘2025년도 일본촉매공업협회 기술상’ 수상
Jun 06, 2025 10:00 HKT
TANAKA PRECIOUS METAL TECHNOLOGIES「PEM型水電解用電極觸媒的開發與實際應用」獲頒「2025年度觸媒工業協會技術獎」
Jun 06, 2025 10:00 HKT
Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: